Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€22.20

€22.20

0.000%
-
0.000%
-
 
25.04.24 / Tradegate WKN: A2P4LJ / Name: Pharmasgp Holding / Stock / ? /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

Pharmasgp Holding SE Stock

The Pharmasgp Holding SE price is unchanged compared to yesterday.

Pros and Cons of Pharmasgp Holding SE in the next few years

Pros
?
B****
?
G***** c******* t* c**********
?
M***** P*******
Cons
?
S********** s********
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'

Comments

systinvest bought the security Pharmasgp Holding SE in his wikifolio Aktienwertselektion mit System.
Show more

News

EQS-Adhoc: PharmaSGP Holding SE proposes an increased dividend of EUR 1.36 per share for 2023
EQS-Adhoc: PharmaSGP Holding SE proposes an increased dividend of EUR 1.36 per share for 2023
EQS-Adhoc: PharmaSGP Holding SE proposes an increased dividend of EUR 1.36 per share for 2023
EQS-News: PharmaSGP exceeds the € 100 million revenues mark in 2023 and plans further profitable growth in 2024
EQS-News: PharmaSGP exceeds the € 100 million revenues mark in 2023 and plans further profitable growth in 2024
EQS-News: PharmaSGP exceeds the € 100 million revenues mark in 2023 and plans further profitable growth in 2024
EQS-News: PharmaSGP continues the profitable growth course of the previous quarters in the third quarter of 2023
EQS-News: PharmaSGP continues the profitable growth course of the previous quarters in the third quarter of 2023
EQS-News: PharmaSGP continues the profitable growth course of the previous quarters in the third quarter of 2023